Full Breakdown
WHO Raises Ebola Risk to “Very High” as Outbreak Spreads in Congo’s Ituri Province
5/22/2026, 8:11:37 PM
Rapid escalation in eastern DRC
The World Health Organization (WHO) upgraded the national risk level for the Bundibugyo strain of Ebola in the Democratic Republic of the Congo (DRC) to “very high” on 22 May 2026. The agency warned that the virus is “spreading rapidly” and that the outbreak now threatens the country’s health system and regional stability.
Background & context
The outbreak was first reported on 15 May in Ituri’s Mongwalu health zone after a health-worker died on 24 April. Initial laboratory testing targeted the more common Zaire strain, producing false-negative results and delaying detection. The region is plagued by armed conflict, massive internal displacement (over 920 000 people) and cross-border mining activity, all of which hinder surveillance and response.
Key figures & groups
- Tedros Adhanom Ghebreyesus, WHO Director-General – leading the risk-assessment revision.
- Anne Ancia, WHO Representative in the DRC – coordinating field operations.
- Jean Kaseya, Africa CDC Director-General – overseeing regional surveillance.
- Julienne Lusenge, president of Women’s Solidarity for Inclusive Peace and Development – voicing community concerns.
- UN Humanitarian Coordinator Tom Fletcher – announcing emergency funding.
Timeline (chronological)
- 24 Apr: First death in Bunia (Ituri).
- 26 Apr: Second case reported; samples sent to Kinshasa.
- 5 May: WHO alerted to ~50 deaths in Mongwalu.
- 14 May: First laboratory confirmation of Ebola; Bundibugyo strain identified.
- 15 May: WHO declares Public Health Emergency of International Concern (PHEIC).
- 22 May: Risk level raised to “very high” nationally; UN releases $60 M; US pledges $23 M.
Data & statistics
- Confirmed cases: 82 (WHO) / 30 (local reports).
- Confirmed deaths: 7 (WHO) / 7 (local).
- Suspected cases: 750 (WHO) / 513 (DRC health ministry) / 300 (other sources).
- Suspected deaths: 177 (WHO) / 131 (France 24) / 135 (DRC ministry).
Why it matters
Bundibugyo Ebola has no licensed vaccine or specific treatment, and its case-fatality rate historically ranges from 30 % to 50 %. The outbreak’s location in a conflict-ridden, highly mobile mining zone raises the risk of cross-border spread to Uganda, South Sudan and Rwanda, threatening regional health security.
Official statements & responses
- WHO: “We are revising our risk assessment to very high at the national level, high at the regional level, and low at the global level.” (Tedros)
- UN: Released $60 million from the Central Emergency Response Fund to accelerate supplies and logistics.
- United States: Pledged $23 million and funding for up to 50 treatment clinics; imposed travel restrictions for travelers from the DRC, Uganda and South Sudan.
- Rwanda: Closed its border with the DRC; Uganda increased screening and cancelled mass gatherings.
Criticism & opposition
Humanitarian leaders cite chronic aid cuts, staff shortages and insufficient personal protective equipment (PPE) as major obstacles. Julienne Lusenge described widespread misinformation and community anger, while Dr. Matthew M. Kavanagh blamed “deep cuts” to surveillance systems for the delayed detection. The Africa CDC warned that travel bans could disrupt humanitarian access.
On-the-ground reports
In Rwampara, youths set fire to an Ebola treatment centre after being denied retrieval of a relative’s body, highlighting mistrust of authorities. Local clinics report “full of suspect cases” with no isolation wards. Health workers at Bunia’s Salama hospital lack masks and hand sanitizer, and many patients are referred to distant treatment centres, increasing exposure risk.
Conflicting reports & gaps
Numbers of suspected cases and deaths vary widely across WHO, DRC ministry, and independent monitors, reflecting limited laboratory capacity and delayed reporting. “Patient zero” remains unidentified, and surveillance data are incomplete for remote mining zones and areas under rebel control.
Verbatim quotes
- “The Ebola outbreak in the Democratic Republic of the Congo is spreading rapidly.” — Tedros Adhanom Ghebreyesus, WHO Director-General
- “Building trust in the affected communities is critical to a successful response.” — Tedros Adhanom Ghebreyesus
- “We are playing catch-up against a very dangerous pathogen.” — Matthew M. Kavanagh, Georgetown University Center for Global Health Policy and Politics
- “The way things are going in Ituri, they are fearing that more cases are spreading because the majority of the cases reported across the region are still coming from Ituri.” — Gabriela Arenas, IFRC Regional Operations Coordinator
- “I don’t think that in two months we will be done with this outbreak.” — Anne Ancia, WHO Representative in the DRC
What’s next
The WHO emergency committee will meet to consider additional recommendations, including the possible use of the experimental antiviral obeldesivir for high-risk contacts. Vaccine candidates for Bundibugyo are projected to enter clinical trials within two to three months, but full licensure may take six to nine months. Continued funding from the UN, United States and other donors, alongside intensified contact-tracing and safe-burial protocols, will be essential to contain the outbreak.
